Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 September 2019 | Story Xolisa Mnukwa | Photo Xolisa Mnukwa
Koffie Yinkah
“I believe the Hesselbein Global Academy annual fellowship programme was vital for me as a potential public servant of South Africa to serve the people of this country in government one day.” – Kofi Yinkah

University of the Free State (UFS) third-year BAdmin student, Kofi Annan Yinkah, formed part of the Hesselbein Global Academy annual fellowship programme, hosted by the University of Pittsburgh in the United States of America (USA). Originally from the East Rand in Johannesburg, Kofi represented the UFS as one of the top-50 students who were selected out of 450 global applicants.

The Hesselbein Global Academy annual fellowship programme aims to connect young leaders from all over the world with well-equipped professionals who are leaders in the fields of business, government, and education. This programme was established for the purpose of cultivating and producing cadres who will become experienced ethical leaders, armed and qualified enough to address and solicit solutions for critical issues experienced by diverse societies throughout the world.

“The fellowship covered topics that have helped to broaden my critical thought processes and concerns about societal issues in our country and all over the world. It has also emphasised the importance of implementing change through effective governing-policy development and establishment,” Kofi says.

He describes his experience at the fellowship as “out of the ordinary,” and believes that it has had a progressive influence on his life. He explains how it has unlocked his mind through enlightened engagement with student leaders from various countries in the world, including Nigeria, England, Canada, Chile, Trinidad and Tobago, Vietnam, China, United States of America, and Ireland.

One of the most important tools he believes his experience has equipped him with, is understanding the significance of employing a solution-driven approach to various situations. He is confident that this will give him the necessary skills and knowledge to work effectively in teams.

Kofi explains that he found out about the fellowship programme via social media. He encourages UFS students to use online platforms to source information about opportunities that can offer them meaningful experiences for learning and growing. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept